Literature DB >> 15046435

Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft.

W Zhen1, H Yaotian, L Songjian, L Ge, W Qingliang.   

Abstract

Giant-cell tumour of bone (GCT) is a locally benign aggressive tumour. The use of adjuvant agents, such as phenol or liquid nitrogen has been recommended to destroy the remaining tumour cells after curettage, and filling of the defect with methylmethacrylate cement has been advocated. Between 1957 and 1992 we treated 92 patients with a GCT with 50% aqueous zinc chloride solution and bone grafting. Their mean age at the time of surgery was 31 years (15 to 59) and the mean follow-up was 11 years (5 to 31). Twelve (13%) had a local recurrence and one had a wound infection. Two developed degenerative changes around the knee. Eighty-six (93%) achieved good or excellent function. Three had moderate function, and three needed amputation. Our findings indicate that treatment with an aqueous solution of zinc chloride and reconstructive bone grafting after curettage gives good results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046435     DOI: 10.1302/0301-620x.86b2.14362

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  43 in total

1.  Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis.

Authors:  Yu-Peng Liu; Kang-Hua Li; Bu-Hua Sun
Journal:  Clin Orthop Relat Res       Date:  2012-07-07       Impact factor: 4.176

2.  A novel approach to juxta-articular aggressive and recurrent giant cell tumours: resection arthrodesis using bone transport over an intramedullary nail.

Authors:  S Vidyadhara; Sharath K Rao
Journal:  Int Orthop       Date:  2006-05-25       Impact factor: 3.075

3.  Giant cell tumor of upper thoracic spine.

Authors:  Chul Gab Lee; Sung Hoon Kim; Dong Min Kim; Seok Won Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-03-31

4.  Orthopaedic . Radiology . Pathology Conference: Painful distal femur Lesion in a 13-year-old girl.

Authors:  Asheesh Harsha; Camilo E Villalobos; Leon D Rybak; Dariusz Borys; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

5.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

6.  Similar local control between phenol- and ethanol-treated giant cell tumors of bone.

Authors:  Wei-Hsin Lin; Tsung-Yu Lan; Chih-Yu Chen; Karl Wu; Rong-Sen Yang
Journal:  Clin Orthop Relat Res       Date:  2011-07-06       Impact factor: 4.176

7.  Ossified soft tissue recurrence of giant cell tumor of the bone: four case reports with follow-up radiographs, CT, ultrasound, and MR images.

Authors:  Sun-Young Park; Min Hee Lee; Jong Suk Lee; Joon Seon Song; Hye Won Chung
Journal:  Skeletal Radiol       Date:  2014-05-11       Impact factor: 2.199

8.  Joint preservation after extensive curettage of knee giant cell tumors.

Authors:  Miguel A Ayerza; Luis A Aponte-Tinao; German L Farfalli; Carlos A Lores Restrepo; D Luis Muscolo
Journal:  Clin Orthop Relat Res       Date:  2009-06-10       Impact factor: 4.176

9.  A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.

Authors:  Ira J Miller; Alan Blank; Suellen M Yin; Allison McNickle; Robert Gray; Steven Gitelis
Journal:  Diagn Pathol       Date:  2010-09-22       Impact factor: 2.644

10.  Bone defects following curettage do not necessarily need augmentation.

Authors:  Martti Hirn; Uday de Silva; Sujith Sidharthan; Robert J Grimer; Adesegun Abudu; Roger M Tillman; Simon R Carter
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.